4.4 Review

Cytokines in Systemic Lupus Erythematosus

Journal

CURRENT MOLECULAR MEDICINE
Volume 9, Issue 3, Pages 242-254

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156652409787847263

Keywords

-

Funding

  1. National Institutes of Health
  2. Arthritis Foundation Southern California Chapter
  3. Arthritis National Research Foundation

Ask authors/readers for more resources

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies that can form immune complexes and deposit in tissues, causing inflammation and organ damage. There is evidence that interferons and some interleukins can have an active role in the pathogenesis of SLE and can contribute significantly to the immune imbalance in the disease, whereas the role of some cytokines (such as TNF) is still debated. This review discusses the activity of several cytokines in SLE, their effects on the immune cells in relation to the disease pathogenesis, and the promise and limitations of cytokine-based therapies in clinical trials for lupus patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available